Radiation oncology firm Accuray posted a slight increase in revenue for its 2018 fiscal third quarter but also a higher net loss.
For the period (end-March 31), the company's revenue reached $99.8 million, up 3% from the $97.3 million reported in the 2017 fiscal third quarter. Accuray attributed the increase to a boost in service revenue. However, it also had a net loss of $8.9 million, compared with a net loss of $5 million for the same quarter a year ago.
